| Regulatory
Matters |
| |
Antipsychotic
drugs |
| |
Belatacept |
| |
Dexrazoxane |
| |
Epoetin
alfa and Darbepoetin alfa |
| |
Finasteride
and Dutasteride |
| |
H1N1
influenza vaccine (Pandemrix) |
| |
Leflunomide |
| |
Linezolid |
| |
Methylene
blue |
| |
Metoclopramide |
| |
Nimesulide |
| |
Paracetamol |
| |
Pioglitazone |
| |
Simvastatin |
| |
Simvastatin
and Atorvastatin |
| |
Tamoxifen |
| |
Thalidomide |
| |
Valproate
sodium, divalproex sodium, valproic acid |
| |
Varenicline |
|
Safety of Medicines |
| |
Amiodarone |
| |
Clozapine |
| |
Dronedarone |
| |
Drospirenone-containing
combined oral contraceptives |
| |
Liraglutide
[rDNA origin] Injection |
| |
Rituximab |
| |
Risperidone
and Ropinirole |
| Feature |
| |
Kenya
hosts two pharmacovigilance training courses |